iFabric rolls out Frontline brand at Canadian retailer

Executive Summary

• iFabric Corp.'s subsidiary, Intelligent Fabric Technologies (North America) Inc. (IFTNA), has launched "Frontline," a new brand of clinically validated anti-microbial medical scrubs, at a major Canadian wholesale club retailer.
• The launch marks a significant commercial milestone, establishing IFTNA as a full-scope partner delivering proprietary technologies from chemistry development through finished consumer products at major retail scale.
• Frontline scrubs utilize IFTNA's PROTX2 anti-microbial technology and ecoPEL fluorine-free durable water repellent technology, both of which were validated in a peer-reviewed clinical trial published in the Journal of Hospital Infection.

Key Details

• Product Launch: Introduction of "Frontline," a medical apparel (scrubs) brand engineered and manufactured by IFTNA.
• Retail Partner: A major Canadian wholesale club retailer (specific name not disclosed in the release).
• Technology Stack:
  • PROTX2: Anti-microbial and anti-odour protection engineered for durability through the life of the garment.
  • ecoPEL: Fluorine-free (PFAS-free) durable water repellent technology designed to maintain fabric comfort and breathability.
• Clinical Validation: The technology combination was validated in a clinical trial demonstrating statistically significant reductions in surface bacterial contamination on treated scrubs compared to untreated scrubs in real-world health care environments. Results were peer-reviewed and published in the Journal of Hospital Infection.
• Distribution Channel: Initial launch is on the wholesaler's national e-commerce platform.
• Future Expansion: Potential for expansion to additional product assortments and brick-and-mortar locations subject to member adoption and retailer planning.
• Strategic Significance: This is the second major retail adoption of IFTNA's performance apparel technologies, validating the company's ability to deliver end-to-end programs (branding, design, development, manufacturing) at scale.
• Market Context: Addresses growing demand from health care professionals for anti-microbial solutions supported by rigorous clinical data rather than marketing claims.

Notable Quotes

• "Frontline scrubs translate peer-reviewed clinical evidence into accessible, everyday apparel built for the realities of modern health care -- long shifts, frequent laundering, and regular exposure to bacteria from fluids and surfaces," said Giancarlo Beevis, president and chief executive officer of IFTNA.
• "By combining PROTX2 anti-microbial protection with ecoPEL water-repellent durability and sustainable chemistry, we're delivering clinically validated performance through one of North America's most trusted, value-focused retail platforms."
• "Health care professionals have increasingly demanded anti-microbial solutions supported by rigorous clinical data rather than marketing claims alone... The peer-reviewed validation of our technology platform, combined with adoption by major retail partners, positions IFTNA to address what we believe is a substantial and growing demand for clinically proven infection control apparel in health care settings."